NYSE:DVAHealthcare
DaVita (DVA) Could Be 11% Undervalued Ahead Of Its August 4 Earnings Report
Investor focus on DaVita (DVA) has intensified ahead of the August 4 earnings report, as recent solid quarterly results and upbeat estimate revisions clash with concerns about slower sales volumes and modest projected growth.
See our latest analysis for DaVita.
DaVita's recent share price return has been strong, with a 57.55% 3 month gain and 109.12% year to date, while the 1 year total shareholder return of 64.04% points to momentum that has been building rather than fading.
If strong recent...